Ranger Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-468,796
| Closed | -$15.5M | – | 124 |
|
|
2019
Q2 | $15.5M | Sell |
468,796
-4,955
| -1% | -$164K | 1.06% | 42 |
|
|
2019
Q1 | $16.6M | Buy |
473,751
+55,718
| +13% | +$1.95M | 1.2% | 41 |
|
|
2018
Q4 | $13.9M | Sell |
418,033
-182,431
| -30% | -$6.06M | 1.13% | 38 |
|
|
2018
Q3 | $30.2M | Buy |
600,464
+131,531
| +28% | +$6.62M | 2% | 22 |
|
|
2018
Q2 | $28.1M | Sell |
468,933
-13,697
| -3% | -$820K | 1.96% | 19 |
|
|
2018
Q1 | $22.1M | Sell |
482,630
-63,839
| -12% | -$2.92M | 1.63% | 28 |
|
|
2017
Q4 | $21.8M | Sell |
546,469
-442,371
| -45% | -$17.6M | 1.6% | 28 |
|
|
2017
Q3 | $39.6M | Sell |
988,840
-124,415
| -11% | -$4.98M | 2.97% | 9 |
|
|
2017
Q2 | $48M | Sell |
1,113,255
-369,280
| -25% | -$15.9M | 3.42% | 3 |
|
|
2017
Q1 | $46.4M | Buy |
1,482,535
+40,131
| +3% | +$1.26M | 3.37% | 2 |
|
|
2016
Q4 | $36.4M | Sell |
1,442,404
-49,431
| -3% | -$1.25M | 2.59% | 4 |
|
|
2016
Q3 | $36.9M | Sell |
1,491,835
-824,727
| -36% | -$20.4M | 2.65% | 2 |
|
|
2016
Q2 | $47.2M | Sell |
2,316,562
-94,024
| -4% | -$1.92M | 2.91% | 5 |
|
|
2016
Q1 | $36.8M | Buy |
2,410,586
+425,608
| +21% | +$6.49M | 2.25% | 15 |
|
|
2015
Q4 | $26.7M | Buy |
1,984,978
+424,525
| +27% | +$5.71M | 1.57% | 28 |
|
|
2015
Q3 | $21.9M | Buy |
1,560,453
+157,939
| +11% | +$2.22M | 1.23% | 37 |
|
|
2015
Q2 | $23.8M | Buy |
1,402,514
+1,251,014
| +826% | +$21.2M | 1.16% | 33 |
|
|
2015
Q1 | $1.83M | Buy |
151,500
+3,370
| +2% | +$40.8K | 0.09% | 74 |
|
|
2014
Q4 | $1.23M | Buy |
+148,130
| New | +$1.23M | 0.06% | 81 |
|